top of page
Search
Recent Posts
See AllRS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreve
Cambridge, Mass., Sept 12, 2023 – RS Oncology, a clinical stage biotechnology company developing innovative therapies to eradicate mesothelioma and other diseases, today announced the completion of th
bottom of page